NEW YORK (GenomeWeb News) – Purdue University has received a $1 million grant from the W.M. Keck Foundation to develop technologies to alter epigenetic marks in the genome that turn genes on and off.

The research, the university said, may result in new ways of treating genetic diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.